As miRNAs are yet to be efficaciously implemented as therapeutics in the clinic, we chose to study the effects of the validated miR-1304-5p target, NRAS whose expression also has prognostic significance in NB (Fig. 3F and Supplementary Fig. 5F–K). This evidence concerns the gene NRAS and neuroblastoma.